Compound 1 - (1 - methyl - 1h-pyrazol-4-yl) - N - ((1R, 5S, 7S) - 9 - methyl - 3 - oxa - 9 - azabiciclo [3.3.1] - Nonan - 7 - yl) - 1H indole - 3 - 5 carboxamide, receptor antagonist - HT3； Pharmaceutical Composition and its use as medicine

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

发明人:

MONENSCHEIN, HOLGER,HITCHCOCK, STEPHEN,REICHARD, HOLLY,SUN, HUIKAI,KIKUCHI, SHOTA,MACKLIN, TODD,HOPKINS, MARIA

申请号：

CL2015000121

公开号：

CL2015000121A1

申请日:

2015.01.16

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.Compuesto 1-(1-metil-1H-pirazol-4-il)-N-((1R,5S,7S)-9-metil-3-oxa-9-azabiciclo[3.3.1]-nonan-7-il)-1H-indol-3-carboxamida, antagonista del receptor de 5-HT3； composición farmacéutica； y su uso como medicamento en trastornos neurodegenerativos, psiquiátricos y trastornos gastrointestinales, entre otros.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/